伏隔核对奖赏预期的活动调节早期行为抑制与青少年至成年期焦虑抑郁症状变化的关联
该前瞻性纵向研究在美国招募165名4月龄婴儿,随访至26岁,考察青春期伏隔核对奖赏预期的激活是否调节早期行为抑制(BI)与焦虑抑郁症状变化的关系。结果显示伏隔核激活减弱调节BI与抑郁症状增加及26岁时更多抑郁症状的关联,但与焦虑无显著交互。
要点
- 伏隔核对奖赏预期激活减弱调节早期BI与抑郁症状增加的关联。
- 该调节作用见于抑郁症状变化及26岁时抑郁症状,未见焦虑。
- 尾状核与壳核活动未调节上述关联。
核心结论
- 腹侧纹状体奖赏敏感性减弱可能是连接童年抑制气质与成年过渡期抑郁的发展风险因素。
研究设计与样本
- 前瞻性纵向研究,1989至1993年在美国招募4月龄婴儿,随访至2018年(26岁),数据分析于2021年9月至2022年3月。
- 婴儿期(14和24月龄)用观察范式测BI,青春期(15-18岁)用fMRI货币激励延迟任务测奖赏预期脑活动,15和26岁自报焦虑抑郁症状。
- 采用潜变化分数模型检验调节作用,并以纹状体感兴趣区(伏隔核、尾状核头、尾状核体、壳核)限制统计检验。
主要发现
- 初步分析显示15至26岁焦虑和抑郁症状显著增加,且变化幅度存在个体差异。
- 伏隔核对奖赏预期激活减弱调节早期BI与抑郁症状增加(β=-0.32;b=-4.23;95%CI,-7.70至-0.76;P=.02)及26岁时更多抑郁症状(β=-0.47;b=-5.09;95%CI,-7.74至-2.43;P<.001)的关联。
- 焦虑的潜变化及26岁时焦虑均无显著交互;尾状核和壳核活动未调节这些关联。
临床怎么用
- 对焦虑青少年可关注奖赏加工与动机缺陷,作为预防后续抑郁的潜在干预靶点。
局限性
- 样本以白人为主(162/165,98%),女性84人(50.1%),外推需谨慎。
- fMRI可用数据83人,症状分析n=108,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The early childhood temperament of behavioral inhibition (BI), characterized by inhibited and fearful behaviors, has been associated with heightened risk for anxiety and depression across the lifespan. Although several neurocognitive correlates underlying vulnerability to the development of anxiety among inhibited children have been identified, little is known about the neurocognitive correlates underlying vulnerability to the development of depression. OBJECTIVE: To examine whether blunted striatal activation to reward anticipation, a well-documented neurocognitive vulnerability marker of depression, moderates the association between early BI and the developmental changes in depression and anxiety from adolescence to adulthood. DESIGN, SETTING, AND PARTICIPANTS: Participants in this prospective longitudinal study were recruited at age 4 months between 1989 and 1993 in the US. Follow-up assessments extended into 2018 (age 26 years). Data were analyzed between September 2021 to March 2022. MAIN OUTCOMES AND MEASURES: BI was measured through an observation paradigm in infancy (ages 14 and 24 months). Neural activity to anticipated rewards during a monetary incentive delay task was measured using functional magnetic resonance imaging in adolescence (between ages 15-18 years; 83 individuals had usable data). Anxiety and depressive symptoms were self-reported across adolescence to young adulthood (ages 15 and 26 years; n = 108). A latent change score model, accounting for the interdependence between anxiety and depression, tested the moderating role of striatal activity to reward anticipation in the association between early BI and changes in anxiety and depressive symptoms. A region of interest approach limited statistical tests to regions within the striatum (ie, nucleus accumbens, caudate head, caudate body, putamen). RESULTS: Of 165 participants, 84 (50.1%) were female and 162 (98%) were White. Preliminary analyses revealed significant increases in anxiety and depressive symptoms across ages 15 to 26 years, as well as individual variation in the magnitude of changes. Main analyses showed that reduced activity in the nucleus accumbens to reward anticipation moderated the association between early BI and increases in depressive (β = -0.32; b = -4.23; 95% CI, -7.70 to -0.76; P = .02), and more depressive symptoms at age 26 years (β = -0.47; b = -5.09; 95% CI, -7.74 to -2.43; P < .001). However, there were no significant interactions associated with latent changes in anxiety across age nor anxiety at age 26 years. Activity in the caudate and putamen did not moderate these associations. CONCLUSIONS AND RELEVANCE: Blunted reward sensitivity in the ventral striatum may be a developmental risk factor connecting an inhibited childhood temperament and depression over the transition to adulthood. Future studies should examine the efficacy of prevention programs, which target maladaptive reward processing and motivational deficits among anxious youths, in reducing risks for later depression.
引用
- Tang A, Harrewijn A, Benson B, et al. Striatal Activity to Reward Anticipation as a Moderator of the Association Between Early Behavioral Inhibition and Changes in Anxiety and Depressive Symptoms From Adolescence to Adulthood. JAMA Psychiatry. 2022. PMID: 36287532. doi:10.1001/jamapsychiatry.2022.3483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。